Corporate GovernanceJun 5, 2026, 04:23 PM
Psyence Biomedical Amends 2023 Equity Incentive Plan
AI Summary
Psyence Biomedical Ltd. announced that its board of directors approved an amendment to the 2023 Equity Incentive Plan. This amendment, approved on May 4, 2026, was made to correct a typographical error found in Section 4(b) of the plan. The updated plan is now referred to as the First Amended and Restated Equity Incentive Plan.
Key Highlights
- Psyence Biomedical's Board approved an amendment to the 2023 Equity Incentive Plan on May 4, 2026.
- The amendment corrects a typographical error in Section 4(b) of the Plan.
- The amended plan is referred to as the First Amended and Restated Equity Incentive Plan.
Price Impact
More from PBM